In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing the Risk of Complications 

Nov 16 2024
Convention Center: Ballroom 20 D
12:30 PM - 2:00 PM

World Class Speakers

Ira M. Jacobson
Industry Presenter

Ira M. Jacobson

NYU Hepatology Associates
Paul Y Kwo, MD, FAASLD
Industry Presenter

Paul Y Kwo, MD, FAASLD

Stanford University Medical Center
Nancy Reau, MD, FAASLD
Industry Presenter

Nancy Reau, MD, FAASLD

Rush University Medical Center

Description

Despite safe, effective vaccines and antiviral treatments, HBV infection remains a major health concern. In this event from PeerView, experts explore HBV serologic testing for monitoring disease, evidence-based treatment to achieve a functional cure, and monitoring approaches for treatment response, disease progression, and detection of liver fibrosis, cirrhosis, and HCC. 

Supported by: This educational activity is supported by an independent medical education grant from GSK. 

Organizer: PVI, PeerView Institute for Medical Education

For more information and to register, visit: http://www.PeerView.com/SanDiego-HepB-Live 

Objectives

  • Explain the role of HBV serologic testing, including quantitative hepatitis B surface antigen (qHBsAg) testing, for monitoring disease activity and informing treatment of patients with hepatitis B infection
  • Initiate evidence-based treatment of patients with chronic HBV infection to achieve a functional cure and reduce the risk of complications such as cirrhosis and HCC
  • Implement expert-recommended monitoring approaches for treatment response, disease progression, and detection of liver fibrosis, cirrhosis, and HCC